Previous close | 20.00 |
Open | 20.47 |
Bid | 19.70 x 1000 |
Ask | 20.40 x 800 |
Day's range | 19.56 - 20.50 |
52-week range | 13.16 - 21.00 |
Volume | |
Avg. volume | 733,334 |
Market cap | 7.053B |
Beta (5Y monthly) | 0.46 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
VAUGHAN, Ontario, July 31, 2024--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its second-quarter 2024 financial results.
VAUGHAN, Ontario, July 11, 2024--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter 2024 financial results on Wednesday, July 31, 2024. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of
VAUGHAN, Ontario, July 08, 2024--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today shared results from the company’s inaugural State of Dry Eye survey, which explores dry eye understanding and experiences among American adults. Dry eye is increasingly common and can range from occasional symptoms of dryness to a chronic condition called dry eye disease. Although there is no cure for dry eye, there are vari